Last checked at 1 Dec 2020 07:41
AstraZeneca sells cholesterol drug rights for up to $350m
(Sharecast News) - AstraZeneca said it had agreed to sell the rights to its cholesterol treatment Crestor to Germany's Grunenthal for up to $350m (£261m).
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Astrazeneca Share News (AZN)
AZN Share
Price
AZN Share
News3
AZN Share
Chat
AZN Share
Trades7,837
AZN
Live RNS
AZN Share
Charts
AZN Level 2
Console
AZN Live
Share Price
AZN Broker
Ratings
AZN Directors
Deals
AZN Financial
Diary
AZN
Fundamentals
AZN Short
Positions
AZN
Media
Astrazeneca Information
Share Price Information for Astrazeneca (AZN)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
10,952.00
Bid:
10,950.00
Ask:
10,954.00
Change:
-72.00 (-0.65%)
Spread:
4.00 (0.037%)
Open:
10,882.00
High:
10,966.00
Low:
10,822.00
Prev. Close:
11,024.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.1 Dec 2020 05:10
GLOBAL MARKETS-World shares rise on recovery hopes, following stellar November
(Adds details, updates prices, changes dateline)* World shares up 0.4% after strong European open* China factory activity growth hits 10-yr high in Nov* U.S. dollar weakens, risk-related currencies up* Oil slips after OPEC+ talks delay, copper upBy D...
Read more30 Nov 2020 16:11
UK PM Johnson says hopes vaccines will be approved before Christmas
LONDON, Nov 30 (Reuters) - British Prime Minister Boris Johnson said on Monday he hoped the leading COVID-19 vaccine candidates would be approved by regulators before Christmas."No vaccine has yet got MHRA (Medicines and Healthcare products Regula...
Read more30 Nov 2020 12:42
UPDATE 5-Moderna files for U.S. vaccine authorization, will seek EU nod
* Vaccine 94.1% effective based on full trial results* Efficacy rate consistent across age, race and ethnicity* Moderna shares hit record high above $150* (Adds FDA comment on advisory group meeting)By Julie Steenhuysen and Michael ErmanNov 30 (Reut...
Read more30 Nov 2020 12:42
UPDATE 4-Moderna files for U.S. vaccine authorization, will seek EU nod
* Vaccine 94.1% effective based on full trial results* Efficacy rate consistent across age, race and ethnicity* Moderna shares hit record high above $150* (Adds that Moderna has applied for US emergency authorization)By Julie Steenhuysen and Michael...
Read more30 Nov 2020 12:42
UPDATE 3-Moderna to seek U.S. and EU authorization for its vaccine on Monday
* Vaccine 94.1% effective based on full trial results* Efficacy rate consistent across age, race and ethnicity* Moderna shares hit new record high above $150* FACTBOX-Moderna's mRNA coronavirus vaccine: (Updates Moderna shares)By Julie Steenhuysen a...
Read more30 Nov 2020 12:42
UPDATE 1-Moderna to seek U.S. and EU authorization for its vaccine on Monday
(Adds expert reaction)By Julie Steenhuysen and Michael ErmanNov 30 (Reuters) - Moderna Inc will apply for U.S. and European emergency authorization for its COVID-19 vaccine on Monday after full results from a late-stage study showed it was 94.1% e...
Read more30 Nov 2020 12:42
UPDATE 2-Moderna to seek U.S. and EU authorization for its vaccine on Monday
* Vaccine 94.1% effective based on full trial results* Efficacy rate consistent across age, race and ethnicity* Moderna shares set to hit new record high* FACTBOX-Moderna's mRNA coronavirus vaccine: (Adds more expert comment, Moderna shares)By Julie...
Read more30 Nov 2020 12:07
EXPLAINER-Where are we in the COVID-19 vaccine race?
Dec 11 (Reuters) - Pfizer Inc and BioNTech SE received U.S. regulatory authorization for their COVID-19 vaccine on Friday, making it the first inoculation against the new coronavirus to get a regulatory green light in the United States.The follow...
Read more30 Nov 2020 12:07
EXPLAINER-Where are we in the COVID-19 vaccine race?
Dec 11 (Reuters) - Britain became the first country to roll out the COVID-19 vaccine developed by Pfizer Inc and BioNTech on Dec. 8 after final late-stage trial results showed it was 95% effective in preventing the disease.The following is what we...
Read more30 Nov 2020 12:07
EXPLAINER-Where are we in the COVID-19 vaccine race?
Dec 11 (Reuters) - Britain became the first country to roll out the COVID-19 vaccine developed by Pfizer Inc and BioNTech on Dec. 8 after final late-stage trial results showed it was 95% effective in preventing the disease.The following is what we...
Read more30 Nov 2020 09:49
UK BROKER RATINGS SUMMARY: UBS Upgrades AstraZeneca To Neutral
UK BROKER RATINGS SUMMARY: UBS Upgrades AstraZeneca To Neutral
Read more30 Nov 2020 09:07
AstraZeneca's Forxiga Approved For Use In Japan On Robust Test Results
AstraZeneca's Forxiga Approved For Use In Japan On Robust Test Results
Read more30 Nov 2020 07:43
AstraZeneca's 'Forxiga' gets approval in Japan for heart failure
(Sharecast News) - AstraZeneca announced on Monday that 'Forxiga', or dapagliflozin, has been approved in Japan for the treatment of patients with chronic heart failure, who are receiving standard-of-care.
Read more29 Nov 2020 17:05
India regulators probe alleged AstraZeneca shot reaction, trial continues
By Manoj Kumar and Euan RochaNEW DELHI/MUMBAI, Nov 29 (Reuters) - The Indian Council of Medical Research (ICMR) is assisting an inquiry into an alleged adverse reaction during AstraZeneca's COVID-19 vaccine trial, but has found no reason to recomm...
Read more